Author:
el-Azhary Rokea A.,Patzelt Michelle T.,McBane Robert D.,Weaver Amy L.,Albright Robert C.,Bridges Alina D.,Claus Paul L.,Davis Mark D.P.,Dillon John J.,El-Zoghby Ziad M.,Hickson LaTonya J.,Kumar Rajiv,McCarthy-Fruin Kathleen A.M.,McEvoy Marian T.,Pittelkow Mark R.,Wetter David A.,Williams Amy W.,McCarthy James T.
Reference28 articles.
1. Calcific uremic arteriolopathy in end stage renal disease: pathophysiology and management;Yerram;Ochsner J,2014
2. Calcific uremic arteriolopathy: a call for action;Brandenburg;Semin Nephrol,2014
3. Calciphylaxis: natural history, risk factor analysis, and outcome;Weenig;J Am Acad Dermatol,2007
4. Warfarin, calciphylaxis, atrial fibrillation, and patients on dialysis: outlier subsets and practice guidelines;Eiser;Am J Med,2014
5. Retrospective analysis of tissue plasminogen activator as an adjuvant treatment for calciphylaxis;el-Azhary;JAMA Dermatol,2013
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献